An excess of fragments of amyloid precursor protein (APP), called APP-CTFs, can trigger a mechanism that occurs at the early stages of Alzheimer’s disease. The researchers say understanding the role of APP-CTFs could open avenues for early intervention therapies that could stop or even prevent Alzheimer’s disease. For the past two decades, Alzheimer’s research has […]
Read More